$CCRD
CoreCard Corp Stock $ccrd

$ccrd Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922005090 Filed on March 03, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$13.05M	$48.25M	$9.623M
YoY Change	35.57%	34.5%	-6.57%
Cost Of Revenue	$6.586M	$22.90M	$3.792M
YoY Change	73.68%	48.45%	14.56%
Gross Profit	$6.460M	$25.35M	$5.831M
YoY Change	10.79%	23.97%	-16.58%
Gross Profit Margin	49.52%	52.53%	60.59%
Selling, General & Admin	$1.729M	$4.829M	$1.447M
YoY Change	19.49%	20.79%	28.05%
% of Gross Profit	26.76%	19.05%	24.82%
Research & Development	$1.706M	$8.859M	$1.680M
YoY Change	1.55%	71.92%	-10.64%
% of Gross Profit	26.41%	34.95%	28.81%
Depreciation & Amortization	$1.099M	$3.796M	$678.0K
YoY Change	62.09%	77.38%	142.14%
% of Gross Profit	17.01%	14.98%	11.63%
Operating Expenses	$3.435M	$13.69M	$3.099M
YoY Change	10.84%	49.58%	2.96%
Operating Profit	$3.025M	$11.66M	$2.732M
YoY Change	10.72%	3.21%	-31.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$47.00K	$277.0K	$66.00K
YoY Change	-28.79%	-26.72%	-144.0%
Pretax Income	$3.115M	$11.76M	$2.991M
YoY Change	4.15%	10.67%	-22.51%
Income Tax	$455.0K	$2.724M	$872.0K
% Of Pretax Income	14.61%	23.16%	29.15%
Net Earnings	$2.660M	$9.039M	$2.119M
YoY Change	25.53%	10.76%	-42.73%
Net Earnings / Revenue	20.39%	18.73%	22.02%
Basic Earnings Per Share		$1.03
Diluted Earnings Per Share	$304.6K	$1.03	$235.5K
COMMON SHARES
Basic Shares Outstanding		8.777M
Diluted Shares Outstanding		8.810M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.24M	$29.24M	$37.96M
YoY Change	-22.95%	-22.95%	43.66%
Cash & Equivalents	$29.24M		$37.96M
Short-Term Investments
Other Short-Term Assets	$2.046M	$1.826M	$1.263M
YoY Change	62.0%	44.58%	39.56%
Inventory
Prepaid Expenses
Receivables	$5.547M	$5.547M	$3.270M
Other Receivables	$220.0K	$220.0K	$0.00
Total Short-Term Assets	$36.84M	$36.84M	$42.49M
YoY Change	-13.3%	-13.3%	17.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.37M	$14.33M	$6.914M
YoY Change	50.0%	46.14%	217.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.615M	$6.355M	$1.921M
YoY Change	88.18%	230.82%	-37.63%
Other Assets	$4.585M	$483.0K	$3.020M
YoY Change	51.82%	268.7%	172.56%
Total Long-Term Assets	$21.31M	$21.31M	$14.54M
YoY Change	46.61%	46.61%	78.12%
TOTAL ASSETS
Total Short-Term Assets	$36.84M	$36.84M	$42.49M
Total Long-Term Assets	$21.31M	$21.31M	$14.54M
Total Assets	$58.15M	$58.15M	$57.03M
YoY Change	1.97%	1.97%	28.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.763M	$2.763M	$714.0K
YoY Change	286.97%	286.97%	77.17%
Accrued Expenses	$404.0K	$2.549M	$321.0K
YoY Change	25.86%	14.72%	109.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.85M	$10.85M	$10.06M
YoY Change	7.86%	7.86%	62.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.872M	$2.872M	$1.994M
YoY Change	44.03%	44.03%	315.42%
Total Long-Term Liabilities	$3.421M	$2.872M	$2.812M
YoY Change	21.66%	44.03%	270.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.85M	$10.85M	$10.06M
Total Long-Term Liabilities	$3.421M	$2.872M	$2.812M
Total Liabilities	$14.27M	$14.27M	$12.87M
YoY Change	10.87%	10.87%	85.21%
SHAREHOLDERS EQUITY
Retained Earnings	$39.04M		$30.01M
YoY Change	30.12%		37.36%
Common Stock	$16.35M		$15.93M
YoY Change	2.68%		2.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$11.33M		$1.639M
YoY Change	591.09%
Treasury Stock Shares	$311.5K		$43.57K
Shareholders Equity	$43.87M	$43.87M	$44.15M
YoY Change
Total Liabilities & Shareholders Equity	$58.15M	$58.15M	$57.03M
YoY Change	1.97%	1.97%	28.9%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$2.660M	$9.039M	$2.119M
YoY Change	25.53%	10.76%	-42.73%
Depreciation, Depletion And Amortization	$1.099M	$3.796M	$678.0K
YoY Change	62.09%	77.38%	142.14%
Cash From Operating Activities	$12.07M	$8.915M	$5.782M
YoY Change	108.79%	-57.48%	98.69%
INVESTING ACTIVITIES
Capital Expenditures	-$2.192M	$5.425M	-$702.0K
YoY Change	212.25%	-21.09%	-640.0%
Acquisitions
YoY Change
Other Investing Activities	-$727.0K	-$2.167M	$135.0K
YoY Change	-638.52%	151.98%	-212.5%
Cash From Investing Activities	-$2.919M	-$7.992M	-$567.0K
YoY Change	414.81%	3.26%	126.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$9.688M
YoY Change		491.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-427.0K	-$9.581M	-1.639M
YoY Change	-73.95%	484.56%	-3378.0%
NET CHANGE
Cash From Operating Activities	12.07M	$8.915M	5.782M
Cash From Investing Activities	-2.919M	-$7.992M	-567.0K
Cash From Financing Activities	-427.0K	-$9.581M	-1.639M
Net Change In Cash	8.726M	-$8.712M	3.576M
YoY Change	144.02%	-175.49%	31.96%
FREE CASH FLOW
Cash From Operating Activities	$12.07M	$8.915M	$5.782M
Capital Expenditures	-$2.192M	$5.425M	-$702.0K
Free Cash Flow	$14.26M	$3.490M	$6.484M
YoY Change	119.99%	-75.23%	133.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9001311
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8929368
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8689815
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8885797
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	311496
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37956000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5547000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3270000	USD
CY2021Q4	ccrd	Notes And Interest Receivable Current NotesAndInterestReceivableCurrent	220000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1826000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1263000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	36837000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	43571
CY2020Q4	us-gaap	Assets Current AssetsCurrent	42489000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.50
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.11
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.50
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.11
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29244000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	6355000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	1921000	USD
CY2021Q4	ccrd	Notes And Interest Receivable Noncurrent NotesAndInterestReceivableNoncurrent	147000	USD
CY2020Q4	ccrd	Notes And Interest Receivable Noncurrent NotesAndInterestReceivableNoncurrent	2681000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10371000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6914000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4438000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3020000	USD
CY2021Q4	us-gaap	Assets Assets	58148000	USD
CY2020Q4	us-gaap	Assets Assets	57025000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2763000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	714000	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2263000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1322000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2145000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1901000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	404000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	321000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1004000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	954000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2274000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4850000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10853000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10062000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	549000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	818000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2708000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1994000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3421000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2812000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	90000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	89000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16261000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	15836000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11327000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1639000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-194000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-140000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	39044000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	30005000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43874000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44151000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58148000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57025000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	48248000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35873000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	22902000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	15427000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	279000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	132000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4550000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3866000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8859000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5153000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	11658000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1639000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	11295000	USD
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	-172000	USD
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	-1044000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	277000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	378000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11763000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10629000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2724000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2468000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	9039000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8161000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8777066
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8919602
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8809603
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9014985
CY2021	us-gaap	Profit Loss ProfitLoss	9039000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	8161000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-54000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-46000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8985000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8115000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	37289000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8161000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	386000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-46000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44151000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9688000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	9039000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	318000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-54000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43874000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	9039000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8161000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3796000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2138000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	319000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	386000	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	125000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-227000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	543000	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1009000	USD
CY2021	ccrd	Noncash Interest Income NoncashInterestIncome	-0	USD
CY2020	ccrd	Noncash Interest Income NoncashInterestIncome	131000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-172000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-400000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2277000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5489000	USD
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	125000	USD
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-0	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	605000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	358000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	61000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-22000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	321000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	311000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	244000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-602000	USD
CY2021	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	941000	USD
CY2020	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	633000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	168000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2869000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2945000	USD
CY2021	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	164000	USD
CY2020	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	-23000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8915000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20966000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5425000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6875000	USD
CY2021	ccrd	Payments For Notes And Interest Receivable PaymentsForNotesAndInterestReceivable	550000	USD
CY2020	ccrd	Payments For Notes And Interest Receivable PaymentsForNotesAndInterestReceivable	1000000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	400000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	USD
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1800000	USD
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	183000	USD
CY2021	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	USD
CY2020	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	135000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7992000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7740000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	107000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9688000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1639000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9581000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1639000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-54000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-46000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8712000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11541000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37956000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26415000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29244000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37956000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2767000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1826000	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1728000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates </i>– In preparing the financial statements in conformity with accounting principles generally accepted in the United States, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Areas where we use estimates and make assumptions are to determine our allowance for doubtful accounts, valuation of our investments, depreciation and amortization expense, accrued expenses and deferred income taxes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10371000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5395000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19339000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12309000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8968000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6914000	USD
CY2021Q4	us-gaap	Investments Investments	6355000	USD
CY2020Q4	us-gaap	Investments Investments	1921000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	318000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	386000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	48248000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35873000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	48248000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	35873000	USD
CY2021Q4	ccrd	Ownership Percentage OwnershipPercentage	0.28	pure
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3615000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	172000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	400000	USD
CY2018Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	250000	USD
CY2020Q1	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2020Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	750000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2951000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1925000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-227000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	543000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2724000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2468000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.058	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.047	pure
CY2021	ccrd	Effective Income Tax Rate Reconciliation Equity Compensation Percent EffectiveIncomeTaxRateReconciliationEquityCompensationPercent	0.003	pure
CY2020	ccrd	Effective Income Tax Rate Reconciliation Equity Compensation Percent EffectiveIncomeTaxRateReconciliationEquityCompensationPercent	0.003	pure
CY2021	ccrd	Effective Income Tax Rate Reconciliation Tax Credit Research And Development Percent EffectiveIncomeTaxRateReconciliationTaxCreditResearchAndDevelopmentPercent	0.026	pure
CY2020	ccrd	Effective Income Tax Rate Reconciliation Tax Credit Research And Development Percent EffectiveIncomeTaxRateReconciliationTaxCreditResearchAndDevelopmentPercent	0.025	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	0.013	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	0.027	pure
CY2021	ccrd	Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Inclusion Percent EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeInclusionPercent	0	pure
CY2020	ccrd	Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Inclusion Percent EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeInclusionPercent	0.018	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	896000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1052000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	788000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	259000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	124000	USD
CY2021Q4	ccrd	Deferred Tax Asset Fixed Assets DeferredTaxAssetFixedAssets	-1335000	USD
CY2020Q4	ccrd	Deferred Tax Asset Fixed Assets DeferredTaxAssetFixedAssets	-1347000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	148000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	134000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	32000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	301000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	517000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	517000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	549000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	818000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	500000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2021Q4	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	3955000	USD
CY2020Q4	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	2889000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1239000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1337000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1265000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	910000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	515000	USD
CY2021Q4	ccrd	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	181000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4208000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1239000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1052000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	58000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	46000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	126500
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	126000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67500
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	126500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	881177
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	885620
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	49000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	102500
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.59
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	17.35
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	8.94
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.81
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.61
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1267960	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	49000
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y6M
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	16.81
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1079860	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9039000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8161000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8777000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8920000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	33000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	95000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8810000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9015000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	33000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	95000

Files In Submission

Name	View Source	Status
0001437749-22-005090-index-headers.html	Edgar Link	pending
0001437749-22-005090-index.html	Edgar Link	pending
0001437749-22-005090.txt	Edgar Link	pending
0001437749-22-005090-xbrl.zip	Edgar Link	pending
ccrd-20211231.xsd	Edgar Link	pending
ccrd-20211231_cal.xml	Edgar Link	unprocessable
ccrd-20211231_def.xml	Edgar Link	unprocessable
ccrd-20211231_lab.xml	Edgar Link	unprocessable
ccrd-20211231_pre.xml	Edgar Link	unprocessable
ex_340128.htm	Edgar Link	pending
ex_340129.htm	Edgar Link	pending
ex_340130.htm	Edgar Link	pending
ex_340131.htm	Edgar Link	pending
ex_340132.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ins20211231_10k.htm	Edgar Link	pending
ins20211231_10k_htm.xml	Edgar Link	completed
logo001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCRD
CoreCard Corp Stock $ccrd

2021 Q4 Form 10-K Financial Statement

#000143774922005090 Filed on March 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD CoreCard Corp Stock $ccrd

2021 Q4 Form 10-K Financial Statement

#000143774922005090 Filed on March 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD
CoreCard Corp Stock $ccrd